We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Prism’s Nexterone for Arrhythmia
FDA Approves Prism’s Nexterone for Arrhythmia
January 9, 2009
Prism Pharmaceuticals’ Nexterone treatment for arrhythmia has become the company’s first drug to win FDA approval.